Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Functional complement analysis can predict genetic testing results and long-term outcome in patients with complement deficiencies
Avtorji:ID Blazina, Štefan (Avtor)
ID Debeljak, Maruša (Avtor)
ID Košnik, Mitja, Klinika Golnik, Medicinska fakulteta UL (Avtor)
ID Simčič, Saša (Avtor)
ID Stopinšek, Sanja (Avtor)
ID Markelj, Gašper (Avtor)
ID Toplak, Nataša (Avtor)
ID Kopač, Peter, Klinika Golnik (Avtor)
ID Zakotnik, Breda (Avtor)
ID Pokorn, Marko (Avtor)
ID Avčin, Tadej (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1000,60 KB)
MD5: F47CAB5FA71632612536352BE398A445
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Background: Prevalence of complement deficiencies (CDs) is markedly higher in Slovenian primary immunodeficiency (PID) registry in comparison to other national and international PID registries. Objective: The purposes of our study were to confirm CD and define complete and partial CD in registered patients in Slovenia, to evaluate frequency of clinical manifestations, and to assess the risk for characteristic infections separately for subjects with complete and partial CD. Methods: CD was confirmed with genetic analyses in patients with C2 deficiency, C8 deficiency, and hereditary angioedema or with repeated functional complement studies and measurement of complement components in other CD. Results of genetic studies (homozygous subjects vs. heterozygous carriers) and complement functional studies were analyzed to define complete (complement below the level of heterozygous carriers) and partial CD (complement above the level of homozygous patients). Presence of characteristic infections was assessed separately for complete and partial CD. Results: Genetic analyses confirmed markedly higher prevalence of CD in Slovenian PID registry (26% of all PID) than in other national and international PID registries (0.5–6% of all PID). Complement functional studies and complement component concentrations reliably distinguished between homozygous and heterozygous CD carriers. Subjects with partial CD had higher risk for characteristic infections than previously reported. Conclusion: Results of our study imply under-recognition of CD worldwide. Complement functional studies and complement component concentrations reliably predicted risk for characteristic infections in patients with complete or partial CD. Vaccination against encapsulated bacteria should be advocated also for subjects with partial CD and not limited to complete CD.
Ključne besede:complement deficiency, primary immunodeficiency, laboratory analysis, genetic analysis, clinical manifestations
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Kraj izida:Švica
Založnik:Frontiers Reserach Foundation
Leto izida:2018
Št. strani:str. 1-10
Številčenje:Vol. 9
PID:20.500.12556/DiRROS-12635 Novo okno
UDK:616.9
ISSN pri članku:1664-3224
DOI:10.3389/fimmu.2018.00500 Novo okno
COBISS.SI-ID:4891564 Novo okno
Avtorske pravice:© 2018 Blazina, Debeljak, Košnik, Simčič, Stopinšek, Markelj, Toplak, Kopač, Zakotnik, Pokorn and Avčin
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 17. 8. 2017; Article 500;
Datum objave v DiRROS:12.11.2020
Število ogledov:1365
Število prenosov:594
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in immunology
Skrajšan naslov:Front. immunol.
Založnik:Frontiers Research Foundation
ISSN:1664-3224
COBISS.SI-ID:30774233 Novo okno

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:21.03.2018

Nazaj